As of April 16, 2025, enGene (ENGN) has a market cap of $0.20 billion USD. According to our data, enGene is ranked No.6953 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.20 B |
-39.85%
|
Dec 31, 2024 | $0.34 B |
-27.95%
|
Dec 29, 2023 | $0.47 B |
-10.65%
|
Dec 30, 2022 | $0.53 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Voyager Therapeutics
VYGR
|
$0.18 B |
-0.000 M
|
![]() USA
|
![]() Adverum Biotechnologies
ADVM
|
$67.19 M |
-0.000 M
|
![]() USA
|
![]() uniQure
QURE
|
$0.52 B |
0.000 M
|
![]() Netherlands
|
![]() Generation Bio
GBIO
|
$24.65 M |
0.000 M
|
![]() USA
|
![]() MeiraGTx
MGTX
|
$0.43 B |
0.000 M
|
![]() USA
|
Market Cap | = | ENGN Stock Price | * | ENGN Shares Outstanding |
= | $4.00 | * | 50.98 M | |
= | $0.20 B |